Olanzapine
- Product NDC
- 51293-852
- 11-digit product format
- 512930852
- Labeler code
- 51293
- Product ID
- 51293-852_cdbdaf42-d27b-4a2e-9d0b-f2650a42b397
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Olanzapine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- ECI PHARMACEUTICALS LLC
- Application
- ANDA206155
- Marketing category
- ANDA
- Marketing start
- 2022-01-17
- Marketing end
- 0000-00-00
- Substance
- OLANZAPINE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 51293-852-10 | 51293085210 | 1000 TABLET in 1 BOTTLE (51293-852-10) | 1000 tablet | 2020-08-14 | 0000-00-00 | No | No | Current |
| 51293-852-64 | 51293085264 | 30 TABLET in 1 BOTTLE (51293-852-64) | 30 tablet | 2020-08-14 | 0000-00-00 | No | No | Current |